Cargando…
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extension
BACKGROUND: Current data for the use of dimethyl fumarate (DMF) in Japanese patients with relapsing–remitting multiple sclerosis (RRMS) is limited. OBJECTIVES: To assess the efficacy of DMF in Japanese patients with RRMS. METHODS: The phase 3, multinational APEX study (ClinicalTrials.gov identifier:...
Autores principales: | Kondo, T, Kawachi, I, Onizuka, Y, Hiramatsu, K, Hase, M, Yun, J, Matta, A, Torii, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669851/ https://www.ncbi.nlm.nih.gov/pubmed/31391949 http://dx.doi.org/10.1177/2055217319864974 |
Ejemplares similares
-
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension
por: Ochi, Hirofumi, et al.
Publicado: (2018) -
Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese
patients with multiple sclerosis: Interim analysis of the randomized
placebo-controlled study
por: Mori, Masahiro, et al.
Publicado: (2019) -
Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
por: Gold, Ralf, et al.
Publicado: (2016) -
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies
por: Gold, Ralf, et al.
Publicado: (2016) -
Interim Analysis of Pregnancy Outcomes After Exposure to Dimethyl Fumarate in a Prospective International Registry
por: Hellwig, Kerstin, et al.
Publicado: (2021)